Maynard Um
-
-
-
-
-
-
-
Cullinan Oncology (CGEM) Reiterated at Buy by Stifel on CLN-978 Data
-
-
-
-
-
-
-
Cullinan Oncology, Inc. (CGEM) Tops Q4 EPS by 1c
-
-
-
-
-
-
-
Cullinan Oncology Inc. (CGEM) PT Raised to $38 at BTIG
-
-
-
-
-
-
-
H.C. Wainwright Assumes Cullinan Oncology Inc. (CGEM) at Buy
-
-
-
-
-
-
-
Cullinan Therapeutics (CGEM) Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Cullinan Oncology Inc. (CGEM)
-
-
-
-
-
-
-
Cullinan Therapeutics (CGEM) Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration for CLN-978 to Treat Systemic Lupus Erythematosus
-
436,569 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

